Beauty Health (NASDAQ:SKIN – Get Free Report) and Labcorp (NYSE:LH – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.
Valuation & Earnings
This table compares Beauty Health and Labcorp”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $301.92 million | 0.54 | -$29.10 million | ($0.22) | -5.89 |
| Labcorp | $13.77 billion | 1.62 | $746.00 million | $10.18 | 26.37 |
Volatility and Risk
Beauty Health has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.
Insider & Institutional Ownership
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Comparatively, 0.8% of Labcorp shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings and target prices for Beauty Health and Labcorp, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 4 | 1 | 1 | 2.29 |
| Labcorp | 0 | 4 | 12 | 0 | 2.75 |
Beauty Health presently has a consensus price target of $2.81, indicating a potential upside of 117.18%. Labcorp has a consensus price target of $297.07, indicating a potential upside of 10.66%. Given Beauty Health’s higher possible upside, analysts clearly believe Beauty Health is more favorable than Labcorp.
Profitability
This table compares Beauty Health and Labcorp’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -3.87% | -19.70% | -1.97% |
| Labcorp | 6.21% | 15.85% | 7.35% |
Summary
Labcorp beats Beauty Health on 11 of the 15 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
